We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-10.85%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$9.04B
AUM Growth
-$1.43B
(-14%)
Cap. Flow
-$151M
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
18.65%
Holding
2,374
New
143
Increased
1,021
Reduced
923
Closed
229
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$58M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$50M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$34.8M |
| 4 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$19.1M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$16.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$32.9M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$32M |
| 3 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$25M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$23.6M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.77% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4.61% |
| 4 | Consumer Discretionary | 3.54% |
| 5 | Industrials | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PBT
2051
Permian Basin Royalty Trust
PBT
$1.52B
| $84K | ﹤0.01% |
14,166
-28
| -0.2% | -$197 |
|
|
MFM
2052
Aberdeen Municipal Income Fund
MFM
$222M
| $83K | ﹤0.01% |
13,598
-1,346
| -9% | -$8.47K |
|
|
VERO
2053
DELISTED
Venus Concept
VERO
| $78K | ﹤0.01% |
72
| – | – |
|
2054
Aegon
AEG
$13.9B
| $72K | ﹤0.01% |
17,981
-758
| -4% | -$3.7K |
|
2055
Oaktree Specialty Lending
OCSL
$1.13B
| $72K | ﹤0.01% |
5,667
+417
| +8% | +$5.7K |
|
2056
BGC Group
BGC
$4.83B
| $71K | ﹤0.01% |
13,691
-10,855
| -44% | -$71.5K |
|
|
PNNT
2057
Pennant Park Investment Corp
PNNT
$244M
| $71K | ﹤0.01% |
+11,209
| New | +$79.7K |
|
2058
Invesco Senior Income Trust
VVR
$460M
| $70K | ﹤0.01% |
17,965
+4,175
| +30% | +$17.2K |
|
2059
GoPro
GPRO
$114M
| $69K | ﹤0.01% |
16,382
+5,829
| +55% | +$32.6K |
|
2060
Red Violet
RDVT
$1.14B
| $69K | ﹤0.01% |
10,224
-1,857
| -15% | -$12K |
|
2061
Sumitomo Mitsui Financial
SMFG
$160B
| $68K | ﹤0.01% |
10,474
-1,492
| -12% | -$11.1K |
|
2062
Ovintiv
OVV
$17.6B
| $67K | ﹤0.01% |
2,312
-131
| -5% | -$5.65K |
|
|
ASXC
2063
DELISTED
Asensus Surgical, Inc.
ASXC
| $67K | ﹤0.01% |
2,279
+173
| +8% | +$7.86K |
|
|
PIM
2064
Franklin Master Intermediate Income Trust
PIM
$153M
| $65K | ﹤0.01% |
15,342
-2,375
| -13% | -$10.5K |
|
|
XXII
2065
22nd Century Group
XXII
$1.52M
| – | – |
0
| – | – |
|
|
CCEC
2066
Capital Clean Energy Carriers
CCEC
$1.35B
| $65K | ﹤0.01% |
4,420
-926
| -17% | -$16.7K |
|
|
NSLR
2067
Neostellar Capital Corp
NSLR
$282M
| $64K | ﹤0.01% |
14,601
+1,310
| +10% | +$7.22K |
|
2068
NovaGold Resources
NG
$3.37B
| $63K | ﹤0.01% |
15,979
-2,506
| -14% | -$9.89K |
|
2069
Vuzix
VUZI
$220M
| $63K | ﹤0.01% |
13,100
-2,900
| -18% | -$16.9K |
|
|
ODP
2070
DELISTED
ODP
ODP
| $62K | ﹤0.01% |
2,387
-6
| -0.3% | -$172 |
|
2071
Avalo Therapeutics
AVTX
$1.04B
| $61K | ﹤0.01% |
7
-6
| -46% | -$66.9K |
|
2072
Cumberland Pharmaceuticals
CPIX
$119M
| $60K | ﹤0.01% |
10,000
| – | – |
|
|
GUT
2073
Gabelli Utility Trust
GUT
$572M
| $60K | ﹤0.01% |
10,375
+42
| +0.4% | +$249 |
|
2074
MannKind Corp
MNKD
$1.23B
| $59K | ﹤0.01% |
55,407
+36,694
| +196% | +$62.3K |
|
2075
BlackRock Income Trust
BKT
$340M
| $57K | ﹤0.01% |
3,389
-707
| -17% | -$12K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, Cambridge Investment Research Advisors held 2,374 positions worth $9.04B, down 14% from $10.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors's Q4 2018 filing shows 143 new, 1,021 increased, 923 reduced and 229 closed positions. Its largest new stake was PIMCO Enhanced Low Duration Active Exchange-Traded Fund: 78,644 shares worth $7.77M. The largest sale was Invesco QQQ Trust, an estimated $32.9M.
By sector, the portfolio is most concentrated in Technology at 5.8% of assets, down from 6.6% a quarter earlier, followed by Financials and Healthcare.
- Cambridge Investment Research Advisors's largest Q4 2018 buy was PIMCO Enhanced Low Duration Active Exchange-Traded Fund: 78,644 shares worth $7.77M.
- Cambridge Investment Research Advisors added most to Vanguard Short-Term Treasury ETF in Q4 2018, an estimated $58M increase.
- Cambridge Investment Research Advisors's biggest Q4 2018 reduction was Invesco QQQ Trust, cutting an estimated $32.9M.
- Cambridge Investment Research Advisors fully exited iShares US Oil & Gas Exploration & Production ETF in Q4 2018, selling an estimated $17M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $9.04B portfolio in Q4 2018.
- Cambridge Investment Research Advisors opened 143 new positions and closed 229 in Q4 2018.
- Cambridge Investment Research Advisors's portfolio value fell 14% quarter-over-quarter to $9.04B.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.